671386

Philip NMI Raskin — FEI 3008281994

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 23, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dallas, TX (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance